Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized dose-finding and pharmacokinetic study of intraventricular alteplase for intraventricular hemorrhage
2004-000919-26Phase 2Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Jun 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of tissue-plasminogen activator in intracerebral hemorrhage (ICH) and Intraventricular hemorrhage (IVH) (2 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoints: 30-day mortality, Incidence of ventriculitis and 2 more. Started Jun 2005; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
intracerebral hemorrhage (ICH)Intraventricular hemorrhage (IVH)
Beyond the preview
Go deeper on 2004-000919-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000919-26.